Triggers of elevated ceramide levels comprise hyperosmotic shock [122], secreted sphingomyelinases (SMases) during inflammation [125], sepsis [126] or severe coronavirus disease 2019 (COVID-19) [127], Clostridium perfringens epsilon toxin [128], and platelet-activating factor [129]
All current information points in the direction of a valid somatic reason, and not the so-called placebo effect, the belief that the need for more frequent injections is in the mind
Potential Benefits of Low-Dose GLP-1 Blockers While research is still early, clinicians are exploring this therapy for individuals dealing with: Chronic low-grade inflammation Fatigue, joint stiffness, and inflammatory markers that remain elevated even with lifestyle interventions
Prion-like transmission of protein aggregates in neurodegenerative diseases
10.1016/j.mtbio.2021.100121 121 WalshM